Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
1. STOCK NEWS:
- Micron (MU) price targets were raised at several firms after the company reported fiscal Q2 results and a Q3 outlook that was largely in-line with market expectations [read more]
- Macy's (M) announced CEO Jeff Gennette will retire and Tony Spring will succeed him in the top post [read more]
- Further to the announcement regarding the acquisition of Credit Suisse (CS), the board of directors of UBS have appointed Sergio Ermotti as Group CEO and President [read more]
- Lululemon (LULU) shares have jumped and seen at least two upgrades following the company's quarterly report [read more]
- Nano Dimension (NNDM) upped its offer to acquire Stratasys (SSYS) to $19.55 per share [read more]
2. WALL STREET CALLS:
- Susquehanna upgrades Carnival with liquidity concerns seen being "effectively de-risked" [read more]
- Hershey (HSY) upgraded to Equal Weight on pricing tailwinds at Wells Fargo [read more]
- Foot Locker (FL), Urban Outfitters (URBN), Burlington Stores (BURL) and Ross Stores (ROST) were all downgraded to Sell at UBS [read more]
- Ciena (CIEN) downgraded to Equal Weight at Morgan Stanley day after being raised to Strong Buy at Raymond James [read more]
- Daiwa initiated coverage of Deere (DE) with an Outperform rating [read more]
3. AROUND THE WEB:
- Cardinal Health (CAH) exploring possible sale of nuclear medicine unit, Bloomberg says [read more]
- Carl Icahn want to bring former CEO Jay Flately back to Illumina (ILMN), WSJ reports [read more]
- Lyft (LYFT) CEO says not up for sale, Bloomberg reports [read more]
- JPMorgan (JPM) CEO Dimon to be deposed over bank’s ties to Epstein, Bloomberg reports [read more]
- First Republic (FRC) no longer up for sale, FBN says [read more]
4. MOVERS:
- Arcturus Therapeutics (ARCT) higher after reporting quarterly results [read more]
- Emergent BioSolutions (EBS) gains after FDA approves over-the-counter Narcan [read more]
- Kingsoft Cloud (KC) rises in New York after reporting quarterly results and providing Q1 guidance [read more]
- Bluebird bio (BLUE) and Sharecare (SHCR) lower after reporting quarterly results [read more]
- SomaLogic (SLGC) falls after reporting quarterly results and providing FY23 guidance [read more]
5. EARNINGS/GUIDANCE:
- Cal-Maine Foods (CALM) reported what CEO Sherman Miller described as "a solid performance for the third quarter" [read more]
- nCino (NCNO) gave fiscal 2024 revenue growth guidance that analysts called "better than feared" [read more]
- Dave & Buster's (PLAY) reported Q4 comps that Truist said were "strong" [read more]
- Progress Software (PRGS) reported better-than-expected Q1 earnings and revenue [read more]
- Conn's (CONN) reported Q4 revenue that topped consensus and said same store sales decreased 21.8% [read more]
INDEXES:
The Dow rose 323.35, or 1.00%, to 32,717.60, the Nasdaq gained 210.16, or 1.79%, to 11,926.24, and the S&P 500 advanced 56.54, or 1.42%, to 4,027.81.